Novo Nordisk A/S vs Riot Platforms Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Riot Platforms Inc trades at $21.48 (market cap $7.53B). The key difference: Novo Nordisk A/S is far larger — about 29.3× Riot Platforms Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals.
| NVO | RIOT | |
|---|---|---|
Market Cap | $220.53B | $7.53B |
Sector | Health | Technology |
52-Week High | $71.70 | $28.67 |
52-Week Low | $35.29 | $11.03 |
Enterprise Value | $239.49B | $8.20B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →